Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Bombieri, M. Claustres, K. Boeck, N. Derichs, J. Dodge, E. Girodon, I. Sermet, M. Schwarz, M. Tzetis, M. Wilschanski, C. Bareil, D. Bilton, C. Castellani, H. Cuppens, G. Cutting, P. Dřevínek, P. Farrell, J. Elborn, K. Jarvi, B. Kerem, E. Kerem, M. Knowles, M. Macek, A. Munck, D. Radojkovic, M. Seia, D. Sheppard, K. Southern, M. Stuhrmann, E. Tullis, J. Zieleński, P. Pignatti, C. Férec (2011)
Recommendations for the classification of diseases as CFTR-related disorders.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 10 Suppl 2
M. Brennan, I. Schrijver (2016)
Cystic Fibrosis: A Review of Associated Phenotypes, Use of Molecular Diagnostic Approaches, Genetic Characteristics, Progress, and Dilemmas.The Journal of molecular diagnostics : JMD, 18 1
Am J Hum Genet, 51
R. Tomaiuolo, P. Nardiello, P. Martinelli, L. Sacchetti, F. Salvatore, G. Castaldo (2013)
Prenatal diagnosis of cystic fibrosis: an experience of 181 casesClinical Chemistry and Laboratory Medicine (CCLM), 51
G. Matthijs, E. Souche, M. Alders, A. Corveleyn, S. Eck, I. Feenstra, V. Race, E. Sistermans, M. Sturm, M. Weiss, H. Yntema, E. Bakker, H. Scheffer, P. Bauer (2015)
Guidelines for diagnostic next-generation sequencingEuropean Journal of Human Genetics, 24
J. Bobadilla, M. Macek, J. Fine, P. Farrell (2002)
Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screeningHuman Mutation, 19
V. Faà, F. Incani, A. Meloni, D. Corda, M. Masala, A. Baffico, M. Seia, A. Cao, M. Rosatelli (2009)
Characterization of a Disease-associated Mutation Affecting a Putative Splicing Regulatory Element in Intron 6b of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene*The Journal of Biological Chemistry, 284
Am J Hum Genet, 56
M. Taulan, V. Viart, C. Thèze, C. Guittard, J. Altieri, C. Templin, L. Mély, M. Claustres, M. Georges (2012)
Identification of a novel duplication CFTRdup2 and functional impact of large rearrangements identified in the CFTR gene.Gene, 500 2
M. Chillón, T. Dörk, T. Casals, J. Giménez, N. Fonknechten, K. Will, D. Ramos, V. Nunes, X. Estivill (1995)
A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA-->G, produces a new exon: high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype.American journal of human genetics, 56 3
C. Bareil, C. Guittard, J. Altieri, C. Templin, M. Claustres, M. Georges (2007)
Comprehensive and rapid genotyping of mutations and haplotypes in congenital bilateral absence of the vas deferens and other cystic fibrosis transmembrane conductance regulator-related disorders.The Journal of molecular diagnostics : JMD, 9 5
John McArdle1, Laurie Whittaker2 (2009)
Cystic FibrosisSemin Respir Crit Care Med, 30
Lancet, 388
A. Pagin, A. Devos, M. Figeac, Maryse Truant, Christelle Willoquaux, F. Broly, G. Lalau (2016)
Applicability and Efficiency of NGS in Routine Diagnosis: In-Depth Performance Analysis of a Complete Workflow for CFTR Mutation AnalysisPLoS ONE, 11
C. Mattocks, M. Morris, G. Matthijs, E. Swinnen, A. Corveleyn, E. Dequeker, C. Müller, V. Pratt, A. Wallace (2010)
A standardized framework for the validation and verification of clinical molecular genetic testsEuropean Journal of Human Genetics, 18
P. Sosnay, K. Siklosi, F. Goor, Kyle Kaniecki, Haihui Yu, N. Sharma, A. Ramalho, M. Amaral, R. Dorfman, J. Zieleński, David Masica, R. Karchin, Linda Millen, P. Thomas, G. Patrinos, M. Corey, M. Lewis, J. Rommens, C. Castellani, C. Penland, G. Cutting (2013)
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator geneNature genetics, 45
M. Romey, N. Pallares‐Ruiz, A. Mangé, C. Mettling, R. Peytavi, J. Demaille, M. Claustres (2000)
A Naturally Occurring Sequence Variation That Creates a YY1 Element Is Associated with Increased Cystic Fibrosis Transmembrane Conductance Regulator Gene Expression*The Journal of Biological Chemistry, 275
E. Dequeker, M. Stuhrmann, M. Morris, T. Casals, C. Castellani, M. Claustres, H. Cuppens, M. Georges, C. Férec, M. Macek, P. Pignatti, H. Scheffer, M. Schwartz, M. Witt, M. Schwarz, E. Girodon (2009)
Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders – updated European recommendationsEuropean Journal of Human Genetics, 17
I. Lavon, I. Lerer, T. Cohen, A. Avital (1992)
Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.American journal of human genetics, 51 5
C. Castellani, H. Cuppens, M. Macek, J. Cassiman, E. Kerem, P. Durie, E. Tullis, B. Assael, C. Bombieri, A. Brown, T. Casals, M. Claustres, G. Cutting, E. Dequeker, J. Dodge, I. Doull, P. Farrell, C. Férec, E. Girodon, M. Johannesson, B. Kerem, M. Knowles, A. Munck, P. Pignatti, D. Radojkovic, P. Rizzotti, M. Schwarz, M. Stuhrmann, M. Tzetis, J. Zieleński, J. Elborn (2008)
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 7 3
J. Bonini, Jessica Varilh, C. Raynal, C. Thèze, Emmanuelle Beyne, M. Audrézet, C. Férec, T. Bienvenu, E. Girodon, S. Tuffery-Giraud, M. Georges, M. Claustres, M. Taulan-Cadars (2015)
Small-scale high-throughput sequencing–based identification of new therapeutic tools in cystic fibrosisGenetics in Medicine, 17
L. Costantino, L. Claut, V. Paracchini, D. Coviello, C. Colombo, L. Porcaro, P. Capasso, M. Zanardelli, G. Pizzamiglio, D. Degiorgio, M. Seia (2010)
A novel donor splice site characterized by CFTR mRNA analysis induces a new pseudo-exon in CF patients.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 9 6
S. Rechitsky, O. Verlinsky, A. Kuliev (2013)
PGD for cystic fibrosis patients and couples at risk of an additional genetic disorder combined with 24-chromosome aneuploidy testing.Reproductive biomedicine online, 26 5
Biomed Res Int, 2015
V. Precone, V. Monaco, M. Esposito, F. Palma, A. Ruocco, F. Salvatore, V. D’Argenio (2015)
Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and PerspectivesBioMed Research International, 2015
V. D’Argenio, M. Esposito, Antonella Telese, V. Precone, Flavio Starnone, Marcella Nunziato, P. Cantiello, M. Iorio, Eloisa Evangelista, M. D'aiuto, A. Calabrese, G. Frisso, G. D'aiuto, F. Salvatore (2015)
The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.Clinica chimica acta; international journal of clinical chemistry, 446
V. D’Argenio, E. Notomista, M. Petrillo, P. Cantiello, V. Cafaro, Viviana Izzo, B. Naso, L. Cozzuto, Lorenzo Durante, L. Troncone, G. Paolella, F. Salvatore, A. Donato (2014)
Complete sequencing of Novosphingobium sp. PP1Y reveals a biotechnologically meaningful metabolic patternBMC Genomics, 15
AbstractBackground:Many European laboratories offer molecular genetic analysis of the CFTR gene using a wide range of methods to identify mutations causative of cystic fibrosis (CF) and CFTR-related disorders (CFTR-RDs). Next-generation sequencing (NGS) strategies are widely used in diagnostic practice, and CE marking is now required for most in vitro diagnostic (IVD) tests in Europe. The aim of this multicenter study, which involved three European laboratories specialized in CF molecular analysis, was to evaluate the performance of Multiplicom’s CFTR MASTR Dx kit to obtain CE-IVD certification.Methods:A total of 164 samples, previously analyzed with well-established “reference” methods for the molecular diagnosis of the CFTR gene, were selected and re-sequenced using the Illumina MiSeq benchtop NGS platform. Sequencing data were analyzed using two different bioinformatic pipelines. Annotated variants were then compared to the previously obtained reference data.Results and conclusions:The analytical sensitivity, specificity and accuracy rates of the Multiplicom CFTR MASTR assay exceeded 99%. Because different types of CFTR mutations can be detected in a single workflow, the CFTR MASTR assay simplifies the overall process and is consequently well suited for routine diagnostics.
Clinical Chemistry and Laboratory Medicine (CCLM) – de Gruyter
Published: Jun 27, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.